0001437749-18-020549.txt : 20181113 0001437749-18-020549.hdr.sgml : 20181113 20181113151758 ACCESSION NUMBER: 0001437749-18-020549 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 34 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181113 DATE AS OF CHANGE: 20181113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MIKROS SYSTEMS CORP CENTRAL INDEX KEY: 0000317340 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 141598200 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-14801 FILM NUMBER: 181177531 BUSINESS ADDRESS: STREET 1: P O BOX 7189 STREET 2: 707 ALEXANDER RD, BLDG 2, SUITE 208 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6099871513 MAIL ADDRESS: STREET 1: P O BOX 7189 STREET 2: 707 ALEXANDER RD, BLDG 2, SUITE 208 CITY: PRINCETON STATE: NJ ZIP: 08540 10-Q 1 mkrs20180930_10q.htm FORM 10-Q mkrs20180930_10q.htm
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

☒  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018

or

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____to_____.

 

Commission File Number: 000-14801

 

Mikros Systems Corporation

(Exact name of registrant as specified in its charter)

    

Delaware  14-1598200

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

707 Alexander Road, Building Two, Suite 208, Princeton, New Jersey 08540

(Address of Principal Executive Offices)

 

(609) 987-1513

(Registrant’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes    ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes    ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer              ☐   Accelerated filer                      ☐
Non-accelerated filer                ☐   Smaller reporting company   ☒
Emerging growth company    ☐  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐Yes    ☒ No

 

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: There were 35,568,775 issued and outstanding shares of the issuer’s common stock, $.01 par value per share, on November 8, 2018.

 

 

 

 

 

TABLE OF CONTENTS

 

 

    PAGE #
PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements  
     
 

Condensed Balance Sheets as of September 30, 2018 and December 31, 2017 (unaudited)

1

     
 

Condensed Statements of Income and Comprehensive Income for the Three and Nine Months Ended September 30, 2018 and 2017 (unaudited)

2

     
 

Condensed Statement of Stockholders’ Equity for the Nine Months Ended September 30, 2018 (unaudited)

3

     
 

Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2018 and 2017 (unaudited)

4

     
 

Notes to Condensed Financial Statements (unaudited)

5

     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

9

     
Item 4.

Controls and Procedures

14

     
PART II. OTHER INFORMATION  
     
Item 6. Exhibits 15
     
  Signatures 15

 

 

 

 

 

 

Part I Financial Information

 

Item 1 Financial Statements

 

Mikros Systems Corporation

Condensed Balance Sheets

(Unaudited)

 

   

September 30,

   

December 31,

 
   

2018

   

2017

 
                 

Assets

               

Current assets:

               

Cash and cash equivalents

  $ 1,288,806     $ 1,173,177  

Receivables on government contracts

    1,941,582       1,697,997  

Prepaid expenses and other current assets

    81,160       72,542  

Total current assets

    3,311,548       2,943,716  

Property and equipment

               

Equipment

    210,388       171,018  

Leasehold improvements

    21,306       21,306  

Furniture & fixtures

    42,485       37,557  

Less: accumulated depreciation

    (102,342 )     (106,570 )

Property and equipment, net

    171,837       123,311  

Intangible assets

    139,945       137,683  

Less: accumulated amortization

    (69,966 )     (54,101 )

Intangible assets, net

    69,979       83,582  

Deferred tax assets

    55,777       8,745  

Total assets

  $ 3,609,141     $ 3,159,354  

Liabilities and shareholders' equity

               

Current liabilities:

               

Accrued payroll and payroll taxes

  $ 765,816     $ 575,926  

Accounts payable and accrued expenses

    360,697       482,873  

Accrued warranty expense

    130,370       40,000  

Deferred revenue

    25,250       18,750  

Total current liabilities

    1,282,133       1,117,549  

Long-term liabilities

    18,930       21,920  

Total liabilities

    1,301,063       1,139,469  
                 
                 
                 

Shareholders' equity:

               

Preferred stock, convertible, par value $.01 per share, authorized 5,000,000 shares, none issued and outstanding

    -       -  

Common stock, par value $.01 per share, authorized 60,000,000 shares, issued and outstanding 35,568,775 and 35,561,775 shares, respectively

    355,689       355,619  

Capital in excess of par value

    10,101,805       10,087,843  

Accumulated deficit

    (8,149,416 )     (8,423,577 )

Total shareholders' equity

    2,308,078       2,019,885  

Total liabilities and shareholders' equity

  $ 3,609,141     $ 3,159,354  

 

 See Notes to Unaudited Condensed Financial Statement

 

1

 

 

 

Mikros Systems Corporation

Condensed Statements of Income and Comprehensive Income

(unaudited)

 

   

Three Months Ended,

   

Nine Months Ended,

 
   

September 30,

   

September 30,

   

September 30,

   

September 30,

 
   

2018

   

2017

   

2018

   

2017

 
                                 

Contract Revenues

  $ 1,893,945     $ 1,551,620     $ 6,626,716     $ 5,047,456  
                                 

Cost of sales

    776,493       636,128       3,055,932       1,909,246  
                                 

Gross margin

    1,117,452       915,492       3,570,784       3,138,210  
                                 

Expenses:

                               

Engineering

    648,739       530,477       1,882,829       1,587,069  

General and administrative

    413,731       379,407       1,287,668       1,218,694  
                                 

Total expenses

    1,062,470       909,884       3,170,497       2,805,763  
                                 

Income from operations

    54,982       5,608       400,287       332,447  
                                 

Other income:

                               

Interest

    322       701       1,238       2,154  
                                 

Net income before income taxes

    55,304       6,309       401,525       334,601  
                                 

Income tax expense

    18,275       (22,696 )     127,364       139,064  
                                 
                                 

Net income available to common shareholders

  $ 37,029     $ 29,005     $ 274,161     $ 195,537  
                                 

Income per common share - basic

  $ -     $ -     $ 0.01     $ 0.01  
                                 

Basic weighted average number of shares outstanding

    35,568,775       35,555,742       35,308,668       35,246,893  
                                 

Income per common share - diluted

  $ -     $ -     $ 0.01     $ 0.01  
                                 

Diluted weighted average number of shares outstanding

    35,876,540       35,862,205       35,594,805       35,524,857  

 

See Notes to Unaudited Condensed Financial Statements

 

 

2

 

 

 

 

Mikros Systems Corporation

Condensed Statement of Shareholders' Equity

(unaudited)

 

   

Preferred Stock

   

Common Stock

                         
   

$0.01 Par Value

   

$0.01 Par Value

   

Capital in Excess

   

Accumulated

         
   

Number of shares

   

Par Value

   

Number of shares

   

Par Value

   

of Par Value

   

Deficit

   

Total

 

Balance at January 1, 2018

    -     $ -       35,561,775     $ 355,619     $ 10,087,843     $ (8,423,577 )   $ 2,019,885  

Stock compensation

    -       -       -       -       13,682       -       13,682  

Exercise of non-restricted stock awards

    -       -       7,000       70       280       -       350  

Net income

    -       -       -       -       -       274,161       274,161  
                                                         

Balance at September 30, 2018

    -     $ -       35,568,775     $ 355,689     $ 10,101,805     $ (8,149,416 )   $ 2,308,078  

 

See Notes to Unaudited Condensed Financial Statements

 

3

 

 

 

Mikros Systems Corporation

Condensed Statements of Cash Flows

(Unaudited)

 

   

Nine Months Ended September 30

 
   

2018

   

2017

 
                 

Cash flows from operating activities

               

Net income

  $ 274,161     $ 195,537  

Adjustments to reconcile net income to net cash provided by operating activities:

               
                 

Depreciation and amortization

    63,795       33,657  

Deferred taxes

    (47,032 )     63,260  

Share-based compensation expense

    13,682       9,782  

Changes in assets and liabilities:

               

(Increase) decrease in receivables on government contracts

    (243,585 )     339,333  

(Increase) in prepaid expenses and other current assets

    (8,618 )     (27,622 )

Increase in accrued payroll and payroll taxes

    189,890       49,286  

(Decrease) in accounts payable and accrued expenses

    (122,176 )     (140,764 )

Increase (decrease) in accrued warranty expense

    90,370       (240,980 )

Increase in deferred revenue

    6,500       22,500  

(Decrease) in long-term liabilities

    (2,990 )     (1,696 )

Net cash provided by operating activities

    213,997       302,293  

Cash flows from investing activities:

               

Payments related to intangible assets

    (2,263 )     (4,983 )

Purchase of property and equipment

    (96,455 )     (88,739 )

Net cash used in investing activities:

    (98,718 )     (93,722 )

Cash flows from financing activities:

               

Exercise of stock options

    350       12,350  

Net cash provided by financing activities:

    350       12,350  

Net increase in cash and cash equivalents

    115,629       220,921  

Cash and cash equivalents, beginning of period

    1,173,177       858,868  

Cash and cash equivalents, end of period

  $ 1,288,806     $ 1,079,789  

Supplement cash flow information:

               

Cash paid during the period for income taxes

  $ 66,500     $ 70,150  

 

See Notes to Unaudited Condensed Financial Statements

 

 

4

 

 

Mikros Systems Corporation

Notes to Condensed Financial Statements

(unaudited)

 

 

 

Note 1 Basis of Presentation

 

The financial statements included herein have been prepared by Mikros Systems Corporation (the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

 

In the opinion of the Company’s management, the accompanying unaudited interim condensed financial statements contain all adjustments, consisting solely of those which are of a normal recurring nature, necessary to present fairly its financial position as of September 30, 2018, the results of its operations for the three and nine months ended September 30, 2018 and 2017, changes in stockholders’ equity from January 1, 2018 to September 30, 2018 and cash flows for the nine months ended September 30, 2018 and 2017.

 

 

Note 2 Recent Accounting Pronouncements

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, as amended (commonly referred to as ASC 606), which replaces numerous requirements in U.S. GAAP, including industry-specific requirements, and provides companies with a single revenue recognition model for recognizing revenue from contracts with customers and significantly expanded the disclosure requirements for revenue arrangements. The new standard, as amended, was effective for the Company for interim and annual reporting periods beginning on January 1, 2018.

 

As discussed in Note 3, the Company adopted ASC 606 using the modified retrospective transition method. Results for reporting periods beginning after December 31, 2017 are presented under ASC 606, while prior period comparative information has not been restated and continues to be reported in accordance with ASC 605, Revenue Recognition, the accounting standard in effect for periods ended prior to January 1, 2018. Based on contracts in process at December 31, 2017, the Company determined that the impact of the adoption of ASC 606 is immaterial and that the Company will not recognize any of the accelerated net sales at January 1, 2018 in the Company’s statements of operations for any historical or future period.

 

 

Note 3 Significant Accounting Policies

 

Revenue Recognition

 

We provide our products and services under fixed-price and cost-reimbursable contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss. Cost-reimbursable contracts provide for the payment of allowable costs incurred during performance of the contract. We also enter into cost-plus-fixed-fee contracts. The fixed-fee in a cost-plus-fixed-fee contract is negotiated at the inception of the contract and that fixed-fee does not vary with actual costs. We account for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

 

We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether two or more contracts were negotiated and executed at or near the same time or were negotiated with an overall profit objective. If combined, we treat the combined contracts as a single contract for revenue recognition purposes.

 

We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. The products and services in our contracts are typically not distinct from one another due to their complex relationships and the significant contract management functions required to perform under the contract. Accordingly, our contracts are typically accounted for as one performance obligation. Significant judgment is required in determining performance obligations, and these decisions could change the amount of revenue and profit recorded in a given period. We classify net sales as products or services on our consolidated statements of income and comprehensive income based on the predominant attributes of the performance obligations.

 

5

 

 

Mikros Systems Corporation

Notes to Condensed Financial Statements

(unaudited)

 

We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. Our contracts do not include variable consideration. At the inception of a contract we estimate the transaction price based on our current rights and do not contemplate future modifications. Contracts are often subsequently modified to include changes in specifications, requirements or price, which may create new or change existing enforceable rights and obligations. Depending on the nature of the modification, we consider whether to account for the modification as an adjustment to the existing contract or as a separate contract. Generally, modifications to our contracts or delivery orders are distinct and will be accounted for as a separate contract.

 

We recognize revenue as performance obligations are satisfied and the customer obtains control of the products and services. In determining when performance obligations are satisfied, we consider factors such as contract terms, payment terms and whether there is an alternative future use of the product or service. Substantially all of our revenue is recognized over a period of time as we perform under the contract because control of the work in process transfers continuously to the customer. This continuous transfer of control of the work in process to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit, and take control of any work in process.

 

For performance obligations to deliver products with continuous transfer of control to the customer, revenue is recognized based on the extent of progress towards completion of the performance obligation, generally using the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer as we incur costs on our contracts. Under the cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation. For performance obligations to provide services to the customer, revenue is recognized over a period of time based on costs incurred as our customer receives and consumes the benefits.

 

Backlog (i.e., unfulfilled or remaining performance obligations) represents the sales we expect to recognize for our products and services for which control has not yet transferred to the customer. The estimated consideration is determined at the outset of the contract and considers the risks related to the technical, schedule and cost impacts to complete the contract. Periodically, we review these risks and may increase or decrease backlog accordingly. As the risks on such contracts are successfully retired, the estimated consideration from customers may be reduced, resulting in a reduction of backlog without a corresponding recognition of sales. As of September 30, 2018, our ending backlog was $6.5 million. For arrangements with the DoD, we generally do not begin work on contracts until funding is appropriated by the customer. Billing timetables and payment terms on our contracts vary based on a number of factors, including the contract type.

 

Warranty Expense

 

The Company provides a limited warranty, as defined by the related warranty agreements, for its production units. The Company’s warranties require the Company to repair or replace defective products during such warranty period. The Company estimates the costs that may be incurred under its warranty and records a liability in the amount of such costs at the time product revenue is recognized. Factors that affect the Company’s warranty liability include the number of units sold, expected and anticipated rates of warranty claims, and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amount as necessary. During the three months ended September 30, 2018 and 2017, the Company recognized a warranty expense of $75,000 and $0, respectively, and for the nine months ended September 30, 2018 and 2017, the Company recognized a warranty expense (benefit) of $115,000 and $(238,967), respectively. Since the inception of the ADEPT IDIQ contract in March 2010, the Company has delivered 224 ADEPT units. As of September 30, 2018, there were 35 ADEPT units that remain under the limited warranty coverage.

 

The following table reflects the reserve for product warranty activity for:

 

   

September 30,

   

December 31,

 
   

2018

   

2017

 

Balance, beginning of the period

  $ 40,000     $ 240,980  

Provision for product warranty

    115,000       40,000  

Product warranty expirations

    -       (238,967 )

Product warranty costs paid

    (24,630 )     (2,013 )

Balance, end of the period

  $ 130,370     $ 40,000  

 

6

 

 

Mikros Systems Corporation

Notes to Condensed Financial Statements

(unaudited)

 

Research and Development Expense

 

Research and Development expenditures for research and development of the Company's products are expensed when incurred and are included in general and administrative expenses. The Company recognized research and development costs as follows:

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2018

   

2017

   

2018

   

2017

 

Salaries

  $ 7,047     $ 68,158     $ 69,727     $ 159,237  

Other costs

    14,000       12,193       38,401       39,645  
    $ 21,047     $ 80,351     $ 108,128     $ 198,882  

 

Intangible Assets

The majority of the Company’s intangible assets is a license acquired during 2015. In July 2015, the Company purchased certain software products, intellectual property and related assets from VSE Corporation. The primary software programs purchased were the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs. The Diagnostic Profiler software is used worldwide by several multinational companies for optimized maintenance of diverse product lines. The Diagnostic Profiler is also used by the US Air Force for depot test programs, and Prognostics Framework is used by the US Army for several missile defense systems.

 

Licenses are amortized using a straight-line method over their estimated life of six years. For the three and nine months ended September 30, 2018 and 2017, amortization expense related to the Company’s license amounted to $5,250 and $5,250 and $15,750 and $15,750, respectively, and are included in general and administrative expenses on the Statements of Income and Comprehensive Income.

 

 

Note 4 – Income Tax Matters

 

At September 30, 2018, we estimated our annual effective tax rate for 2018 to be 32%. We recognized a tax expense of $18,275 and $127,364 for the three and nine months ended September 30, 2018. At September 30, 2018, the difference from the statutory federal income tax rate is attributable to state income taxes and certain permanent book-tax differences.

 

The Company conducts an on-going analysis to review its net deferred tax asset and the need for a related valuation allowance. As a result of this analysis and the actual results of operations, the Company has (increased) decreased its net deferred tax assets by $(47,032) and $63,260 during the nine months ended September 30, 2018 and 2017, respectively. The change in deferred tax assets is attributable to the changes in various book/tax differences.

 

In December 2017, new legislation was signed into law reducing the corporate U.S. tax rate from 35% to 21% for tax years beginning after December 31, 2017, fully repealing the corporate alternative minimum tax and making the NOL carryforward period indefinite for NOLs generated after 2017. In accordance with ASC Topic 740, deferred tax assets and liabilities are required to be measured at the enacted tax rate expected to apply when temporary differences are to be realized or settled. As of December 31, 2017, the Company re-measured its deferred tax balances based upon the new 21% tax rate.

 

While the Company has completed its provisional analysis of the income tax effects of the new legislation and recorded a reasonable estimate of such effects, the amounts recorded related to the new legislation may differ, possibly materially, due to, among other things, further refinement of the Company’s calculations, changes in interpretations and assumptions that the Company has made, additional guidance that may be issued by the U.S. Government, and actions and related accounting policy decisions the Company may take as a result of this legislation. The Company will complete its analysis over a one-year measurement period ending no later than December 22, 2018, and any adjustments during this measurement period will be included as an adjustment to income tax expense/benefit in the reporting period when such adjustments are determined.

 

7

 

 

Mikros Systems Corporation

Notes to Condensed Financial Statements

(unaudited)

 

 

Note 5 Income Per Share

 

Net income per common share information is as follows:

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2018

   

2017

   

2018

   

2017

 

Basic earnings per common share:

                               

Net income

  $ 37,029     $ 29,005     $ 274,161     $ 195,537  
                                 

Weighted average basic shares outstanding

    35,568,775       35,555,742       35,308,668       35,246,893  
                                 

Basic income per common share

  $ -     $ -     $ 0.01     $ 0.01  
                                 

Dilutive earnings per common share:

                               

Net income allocable to common shareholders

  $ 37,029     $ 29,005     $ 274,161     $ 195,537  
                                 

Weighted average shares outstanding - basic

    35,568,775       35,555,742       35,308,668       35,246,893  

Diluted effect:

                               

Stock options

    76,347       82,200       70,364       75,400  

Unvested restricted stock

    231,418       224,263       215,773       202,564  

Weighted average dilutive shares outstanding

    35,876,540       35,862,205       35,594,805       35,524,857  
                                 

Dilutive income per common share

  $ -     $ -     $ 0.01     $ 0.01  

 

Diluted net income per share for the three and nine months ended September 30, 2018 and 2017 does not reflect the following potential common shares, as the effect would be antidilutive.

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2018

   

2017

   

2018

   

2017

 
                                 

Unvested restricted stock

    70,000       60,000       80,000       60,000  

 

8

 

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This report contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” or “will.” These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. For us, particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: changes in business conditions; a decline or redirection of the U.S. defense budget; the termination of any contracts with the U.S. Government; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; our limited marketing experience; competition between us and other companies seeking Small Business Innovative Research (“SBIR”) grants; competitive pricing pressures; market acceptance of our products under development: delays in the development of products; our ability to adequately integrate our software offerings into our business model, our ability to develop and market solutions for commercial customers, numerous other matters of national, regional and global scale, including those of a political, economic, business and competitive nature; statements of assumption underlying any of the foregoing, as well as other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we assume no duty to update or revise our forward-looking statements.

 

Item 2. Management’s Discussion and Analysis of Financial Position and Results of Operations.

Mikros Systems Corporation (the “Company”, “we” or “us”) designs and manufactures software, hardware and electronic systems used to maintain complex distributed systems. Examples of such systems include defense equipment such as radars and combat systems, and commercial and industrial applications such as printing presses, power distribution, and utility systems, and Federal Aviation Administration (“FAA”) systems.

 

Over the past decade, our principal customer has been the U.S. Department of Defense (DoD), primarily the U.S. Navy. We provide the following two key systems to the Navy for maintenance of radars and combat systems:

 

●     ADEPT®, the Adaptive Diagnostic Electronic Portable Testset, is a PC-based maintenance automation workstation used to maintain the Navy’s premier AN/SPY-1 phased array radar on Cruisers (CG) and Destroyers (DDG).

●     ADSSS®, the ADEPT Distance Support Sensor Suite, is a Condition-Based Maintenance (CBM) system used to monitor Combat System Elements (CSEs) onboard the Littoral Combat Ship (LCS).

 

More recently, we have developed and marketed software products to analyze maintenance data collected from target systems, optimize maintenance procedures, and predict failures. Our Prognostics Framework® (PF) and Diagnostic Profiler® (DP) products provide software capabilities which complement our maintenance hardware products (ADEPT and ADSSS) and allow us to provide complete hardware/software solutions for advanced maintenance, particularly of complex distributed systems. Now that we have a complete hardware/software solution for advanced maintenance, we are expanding into commercial and industrial markets.

 

Product Portfolio

Revenues from our government contracts represented substantially all of our revenues for the nine months ended September 30, 2018. We believe that we can utilize the intellectual property developed under our various SBIR awards to develop proprietary products for both the government and commercial marketplace.

 

Adaptive Diagnostic Electronic Portable Testset (ADEPT). ADEPT is an automated maintenance workstation designed to significantly reduce the time required to align the AN/SPY-1 Radar System aboard U.S. Navy Aegis cruisers and destroyers, while optimizing system performance and readiness. ADEPT Systems are currently deploying on all Aegis CG and DDG platforms to support the AN/SPY1 radar system. Since the system uses commercial instrument case and modules, ADEPT units can be modified to support both preventative maintenance and condition-based maintenance of other radars and complex electronic systems in military or commercial applications. In that regard, we have a service contract with the U.S. Navy to extend ADEPT to a second U.S. Navy radar system, the SPS-49. These services are expected to assist in optimizing performance for the Ballistic Missile Defense Mission. As of the date of this report, we have delivered a total of 224 ADEPT units.

 

9

 

 

ADEPT Distance Support Sensor Suite (ADSSS). In 2013, we started development of ADSSS for the Navy’s Littoral Combat Ship (“LCS”). ADSSS is a network-enabled system that can be configured to monitor multiple shipboard systems and report maintenance data onshore for further analysis to detect trends and predict failures. ADSSS provides an open architecture approach with industry standard hardware, and cybersecurity compliant software to acquire and process system operational and maintenance data. ADSSS fully automates the capture of system operation, environment and maintenance data to provide unattended operation. The system monitors key parameters and sends alert notifications when parameters move out of tolerance. We expect ADSSS to be used on both variants of the LCS, currently planned to be at least 32 ships. ADSSS, with its remote monitoring and prognostics capabilities, has also generated interest in other ship classes, including Aegis, and we are currently pursuing several related opportunities.

 

Diagnostic Profiler. The Diagnostic Profiler is an integrated development environment for developing diagnostic capabilities used in maintenance, embedded diagnostics and troubleshooting applications. The software provides diagnostic services to its host application, including fault call-outs, suggested “next best” test to further isolate faults, and direct maintenance actions. When additional faults are identified, the software prioritizes the fault call-outs by probability. The use of the diagnostic profiler eliminates the need for the development and maintenance of diagnostic flow charts and hard-coded text sequences. This reduces the effort required to correct bugs and design changes and over the life of the system, could result in significant cost savings.

 

Prognostics Framework. Prognostics Framework is an analysis software for framework that implements real-time prognostics, diagnostics, and status monitoring to support embedded prognostic applications, health management systems and condition-based maintenance applications. The Prognostics Framework software institutes an information framework that organizes relevant data related to: (i) the condition of the system; (ii) the system’s ability to perform required functions over specific time intervals; and (iii) the need for maintenance actions and repair parts. The Prognostics Framework has been used to implement a complete health management system on one of the first radar systems to require prognostics as a key element of its overall solutions. Other potential applications include complex computer networks, power generators, power supply, cooling and environmental systems.

 

Government Contracts

In April 2016, we received three contracts to continue logistics support of the ADEPT maintenance automation workstation. A contract valued at approximately $0.3 million to provide ADEPT General Engineering and Support was awarded, along with two other logistics contracts to perform necessary updates, repair and calibration on the ADEPT units, totaling $0.25 million. Along with the contracts received for our ADEPT product, we received a follow on contract in the amount of $0.1 million, for technical support on the USS Fort Worth (LCS3) using the latest version of our ADSSS.

 

In July 2016, we received two additional contract modifications for our current service contract for LCS systems using the ADSSS, which added an additional $4.65 million for ongoing development. This funding extended the program through June 2018 and allows us to perform installations and support for the LCS classes.

 

In September 2016, we were awarded and entered into a multi-year IDIQ contract with the Naval Surface Warfare Center, Port Hueneme Division, relating to our ADSSS product. The contract has a term of five years and provides for the purchase and sale of up to $48 million of ADSSS units and related engineering and logistics support. The IDIQ contract covers the first eight ships of the 28 ship program. The first delivery order in the amount of $3.0 million was awarded on September 15, 2016 to perform installations, support and logistics for the LCS class.

 

In September 2016, we received multiple contracts totaling approximately $0.4 million to continue logistics support of the ADEPT maintenance workstation. These contracts include general engineering support, repair, calibration and training.

 

In February 2017, we were awarded a follow-on multi-year Small Business Innovation Research (SBIR) Phase III IDIQ contract with the Naval Surface Warfare Center, Crane Division, for our ADEPT program. The contract provides for the purchase and sale of up to $35.1 million of ADEPT units and related engineering, such as calibration, repair, training and other logistics services. Since the award, we have received multiple delivery orders, some of which are described below.

 

In March and April 2017, we were awarded the second, third and fourth delivery orders under the ADEPT IDIQ Contract. The second delivery order covers engineering services in the amount of $11.5 million which will be funded incrementally and facilitate the engineering and technical support for the ADEPT program during the next three years. The third delivery order contract for $0.6 million is to provide sustainment services, such as calibration, repair, evaluations, and screenings of ADEPT units to be performed in our Manufacturing and Depot (M&D) Center in Largo, Florida. The fourth delivery order for $0.1 million is to provide training to sailors in the fleet to operate the ADEPT maintenance automation workstation.

 

10

 

 

In April 2017, we received contract awards totaling $2.0 million from the U.S. Navy to extend the capabilities of the ADSSS Condition-Based Maintenance (CBM) system to support a fourth Navy radar system, the MK 99. The SBIR office in Dahlgren, VA provided $0.5 million of the total funding to support this effort.

 

In July 2017 and November 2017, we received modifications which added funding to our ADEPT IDIQ Contract, for engineering services in the amounts of $0.4 million and $0.1 million, respectively. These awards will allow us to continue to support the ADEPT product line in the fleet, implement necessary software enhancements, and provide general support of the program.

 

In August 2017, we received a modification to our ADEPT sustainment delivery order, adding $0.5 million to allow our manufacturing and depot center in Largo, Florida, (“M&D Center”) to continue to provide bi-annual sustainment services for units from the fleet cycling through our M&D Center.

 

In September 2017, we received a delivery order in the amount of $2.4 million for the production and delivery of additional ADEPT units. These new units will continue our fleet support on Aegis cruisers and destroyers in the U.S. Navy. In 2018, we received additional modifications to our ADEPT IDIQ Contract and incremental awards for continued engineering services in the aggregate amount of $0.42 million. This funding will support necessary software enhancements to sustainment services for the ADEPT product out of our M&D Center.

 

In February and March 2018, we received modifications to our ADEPT sustainment delivery orders, adding $0.25 million to allow us to continue to provide bi-annual sustainment services for units from the fleet cycling through the M&D Center. In addition to those sustainment services, it allows our team at the M&D Center to provide training to sailors in the fleet to operate the ADEPT maintenance automation workstation.

 

Between January 2018 through April 2018, we received multiple contract awards which increased funding on our ADEPT IDIQ Contract for Engineering Services. The total amount awarded in the first quarter of 2018 was $0.5 million and an additional $1.6 million was awarded in April 2018. This funding will allow us to continue supporting the ADEPT product line in the fleet and implementing necessary software enhancements to increase readiness.

 

In June 2018, we received the second delivery order on our current multi-year IDIQ contract with the Naval Surface Warfare Center, Port Hueneme Division, relating to our ADSSS product. The award totaling $2.5 million will support the MK 99 FCS development, test and installation.

 

In August 2018, we received a contract modification to add funding to our ADEPT IDIQ contract for engineering services in the amount of $1.3 million. This additional funding will support the ADEPT product line in the fleet, implement necessary software enhancements and provide general support.

 

In September 2018, we received modifications to our ADEPT sustainment delivery orders, adding $0.25 million. This funding allows the M&D Center in Largo, Florida to provide bi-annual sustainment services for units from the fleet.

 

Key Performance Indicator

As substantially all of our revenue is derived from contracts with the Federal government, our key performance indicator is the dollar volume of contracts and task orders awarded to us under our IDIQ contracts. Increases in the number and value of contracts and trade orders awarded will generally result in increased revenues in future periods and, assuming relatively stable variable costs associated with our fulfilling such awards, increased profits in future periods. The timing of such awards is uncertain as we sell to Federal government agencies where the process of obtaining such awards can be lengthy and at times uncertain. As the substantial majority of our revenue in 2017, and expected revenue in 2018, is or will be from sales of ADEPT units and ADSSS systems under our IDIQs contract, continued generation of task orders and our ability to expand the market and potential customer base for ADEPT units will be a key indicator of future revenue. ADEPT units must be serviced and calibrated every two years. Accordingly, as we continue to increase the installed base of ADEPT units and expand the units to other radar systems, we expect to generate future recurring maintenance and service revenue.

 

11

 

 

Outlook

Our strategy for continued growth is based on continuing expansion of our defense business and executing new initiatives to apply our advanced maintenance technology in commercial markets. With regard to the defense industry, we expect to continue expanding our technology base, backlog and revenue by continuing our active participation in the DoD SBIR program and bidding on projects that fall within our areas of expertise. These areas include electronic systems engineering and integration, radar systems engineering, combat/C4I (Command, Control, Communications, Computers & Intelligence) systems engineering, and communications engineering. We believe that we can utilize the intellectual property developed under our various SBIR awards to develop proprietary products, such as ADEPT and ADSSS, with broad appeal in both the government and commercial marketplace. Our state-of-the-art test equipment can be used by many commercial and governmental customers such as the FAA, radio and television stations, cell phone stations, and airlines. Second, we will continue to pursue SBIR projects with the Department of Homeland Security, the U.S. Navy, and other government agencies. Third, we believe that through our marketing of products, such as ADEPT, we will develop key relationships with prime defense contractors. Our strategy is to develop these relationships into long-term, key subcontractor roles on future major defense programs awarded to these prime contractors.

 

With regard to commercial markets, our Diagnostic Profiler and Prognostics Framework software offerings complement our hardware products and allow us to provide complete hardware/software solutions for advanced maintenance applications. Current customers for these systems include major multinational corporations such as HP, which recently extended our Diagnostic Profiler software support for a fifth year. We continue to receive repeat orders from these customers to support their applications. We plan to provide “condition-based maintenance” systems for applications such as FAA radar surveillance and support systems, power distribution and utilities infrastructure, commercial shipping, cooling and environmental systems, and other “complex distributed systems” to commercial customers. In that regard, we are currently developing a condition-based maintenance solution for heating ventilation, air conditioning and refrigeration (HVAC) equipment based on our proprietary Prognostics Framework solution. We have deployed two active pilot systems that are providing key maintenance data on a daily basis to service technicians.

 

In 2018, our primary strategic focus is to continue as a premium provider of R&D and product development services to the defense industry, generate multiple task orders under our two IDIQ contracts, and expand our commercial business through marketing and sales of our Prognostics Framework and Diagnostic Profiler software products. We will also seek to generate incremental revenue through providing light assembly and production services to commercial customers at our M&D Center.

 

Over the longer term, we intend to further develop advanced maintenance technologies and implement these technologies in products for deployment in defense applications and to expand into more commercial applications. We believe that many of our core capabilities, remote monitoring, rugged systems, predictive maintenance and communications expertise, are applicable to other industries that work with complex distributed systems, such as utilities, communications and transportation systems. We are currently in discussions with certain industry participants regarding this initiative.

 

During recent years, the combination of spending caps, discretionary spending cuts, sequestration and further changes in defense spending and priorities have caused, and may in the future continue to cause, delays in funding certain projects. This may negatively impact our revenues and profits.

 

 

Changes to Critical Accounting Policies and Estimates

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, as amended (commonly referred to as ASC 606), which replaces numerous requirements in U.S. GAAP, including industry-specific requirements, and provides companies with a single revenue recognition model for recognizing revenue from contracts with customers and significantly expanded the disclosure requirements for revenue arrangements. The new standard, as amended, was effective for the Company for interim and annual reporting periods beginning on January 1, 2018.

 

We adopted ASC 606 using the modified retrospective transition method. Results for reporting periods beginning after December 31, 2017 are presented under ASC 606, while prior period comparative information has not been restated and continues to be reported in accordance with ASC 605, Revenue Recognition, the accounting standard in effect for periods ending prior to January 1, 2018.

 

Results of Operations

 

Three Months Ended September 30, 2018 and 2017

 

We generated revenues of $1,893,945 during the three months ended September 30, 2018 compared to $1,551,620 during the three months ended September 30, 2017, an increase of $342,325, or 22%. The increase was due primarily to a production order for 26 ADEPT units, increase in revenue from engineering contracts, and the receipt of additional contracts for engineering services, support and repairs and calibration services.

 

12

 

 

Cost of sales consists of direct contract costs including labor, material, subcontracts, warranty expense for ADEPT units that have been delivered, travel, and other direct costs. Cost of sales for the three months ended September 30, 2018 was $776,493 compared to $636,128 for the three months ended September 30, 2017, an increase of $140,365 or 22% and in-line with the increase in revenues. The increase was due primarily to the receipt of a production order for 26 ADEPT units in September 2017, increase in revenues from engineering contracts received in 2017, and the receipt of additional contracts for engineering services, support and repairs and calibration services. As a percentage of revenue, cost of sales was 41% of revenues for both the three months ended September 30, 2018 and 2017, respectively.

 

The majority of our engineering costs consist of (i) salary, wages and related fringe benefits paid to engineering employees, (ii) rent-related costs, and (iii) consulting fees paid to engineering consultants. As the nature of these costs benefit the entire organization and all research and development efforts, and their benefit cannot be identified with a specific project or contract, these engineering costs are classified as part of “engineering overhead” and included in operating expenses. Engineering costs for the three months ended September 30, 2018 were $648,739 compared to $530,477 for the three months ended September 30, 2017, an increase of $118,262, or 22% and in-line with the increase in revenues. The increase in 2018 was due to increases in engineering salaries and fringe benefits for additional employees hired in 2017, incentive compensation and engineering consulting fees.

 

General and administrative expenses consist primarily of salary, intellectual property, consulting fees and related costs, professional fees, business insurance, franchise tax, SEC compliance costs, travel, and unallowable expenses (representing those expenses for which the government will not reimburse us, including independent research and development (IR&D) which consists of research and development expenses unrelated to our defense contracts). General and administrative costs for the three months ended September 30, 2018 were $413,731 compared to $379,407 for the three months ended September 30, 2017, an increase of $34,324, or 9%. The increase was due primarily to increases in salaries, incentive compensation, research and development costs and professional fees.

 

At September 30, 2018, we estimated our annual effective tax rate to be 32%.  We recognized a tax expense of $18,275 for the three months ended September 30, 2018 due primarily to expected net income for the remainder of 2018.  At September 30, 2018, the difference from the expected federal statutory income tax rate is attributable to state income taxes and certain permanent book-tax differences. In December 2017, new legislation was signed into law reducing the corporate U.S. tax rate from 35% to 21% for tax years beginning after December 31, 2017.  Tax expense was $8,000 less under the lower 2018 rate than it would have been using the prior statutory tax rate.

 

Nine Months Ended September 30, 2018 and 2017

 

We generated revenues of $6,626,716 during the nine months ended September 30, 2018 compared to $5,047,456 during the nine months ended September 30, 2017, an increase of $1,579,260 or 31%. The increase was due primarily to a production order for 26 ADEPT units in September 2017, increase in revenue from engineering contracts, and the receipt of additional contracts for engineering services, support and repairs and calibration services.

 

Cost of sales for the nine months ended September 30, 2018 was $3,055,932 compared to $1,909,246 for the nine months ended September 30, 2017, an increase of $1,146,686 or 60%. The increase was due primarily to the receipt of a production order for 26 ADEPT units in September 2017, increase in revenues from engineering contracts received in 2017, and the receipt of additional contracts for engineering services, support and repairs and calibration services. As a percentage of revenue, cost of sales was 46% for the nine months ended September 30, 2018 as compared to 38% of revenues for the nine months ended September 30, 2017. The increase is due to an increase in production costs and other direct costs.

 

Engineering costs for the nine months ended September 30, 2018 were $1,882,829 compared to $1,587,069 for the nine months ended September 30, 2017, an increase of $295,760, or 19%. The increase in 2018 was due to increases in engineering salaries and fringe benefits for additional employees hired in 2017, incentive compensation and engineering consulting fees.

 

13

 

 

General and administrative costs for the nine months ended September 30, 2018 were $1,287,668 compared to $1,218,694 for the nine months ended September 30, 2017, an increase of $68,974, or 6%.

 

At September 30, 2018, we estimated our annual effective tax rate for 2018 to be 32%. We recognized a tax expense of $127,364 for the nine months ended September 30, 2018 primarily due to expected net income for 2018. At September 30, 2018, the difference from the expected federal statutory income tax rate is attributable to state income taxes and certain permanent book-tax differences. In December 2017, new legislation was signed into law reducing the corporate U.S. tax rate from 35% to 21% for tax years beginning after December 31, 2017. Tax expense was $62,000 less under the lower 2018 rate than it would have been using the prior statutory tax rate.

 

Liquidity and Capital Resources

 

Since our inception, we have financed our operations through debt, private and public offerings of equity securities, and cash generated by operations.

 

During the nine months ended September 30, 2018, net cash provided by operations was $213,997 compared to net cash provided by operations of $302,293 during the nine months ended September 30, 2017. The decrease was primarily due to the timing of receipts and payments related to our operating assets and liabilities.

 

Net cash used in investing activities was $98,718 in the nine months ended September 30, 2018 as compared to $92,722 in the nine months ended September 30, 2017, a increase of $4,996. The increase was due to the increase in purchases of equipment and furniture and fixtures related to an expansion of our offices in Pennsylvania.

 

On January 31, 2018, we entered into a $550,000 credit facility with PNC Bank. The facility matures on January 31, 2019 and accrues interest at a variable rate equal to the Daily LIBOR Rate plus 250 basis points. Interest is paid monthly. Principal borrowings may be prepaid at any time without penalty and the facility is secured by substantially all of our assets. The facility contains customary affirmative and negative nonfinancial covenants. As of the date of this report, no amounts were outstanding under the facility.

 

In order to pursue strategic opportunities, obtain additional SBIR contracts, or acquire strategic assets or businesses, we may need to obtain additional financing or seek strategic alliances or other partnership agreements with other entities. In order to raise any such financing, we anticipate considering the sale of additional debt or equity securities under appropriate market conditions. There can be no assurance, assuming we successfully raise additional funds or enter into business alliances, that we will remain profitable or continue to generate positive cash flow.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2018, we did not have any relationships with unconsolidated entities or financial partners, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off- balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

 

Item 4. Controls and Procedures.

 

An evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934) was carried out by us under the supervision and with the participation of our president, who serves as our principal executive officer and principal financial officer. Based upon that evaluation, our president concluded that as of September 30, 2018, our disclosure controls and procedures were effective to ensure (i) that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) that such information is accumulated and communicated to management, including our president, in order to allow timely decisions regarding required disclosure.

 

There were no changes in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) or 15d- 15(f)) that occurred during the fiscal quarter ended September 30, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

14

 

 

PART II. OTHER INFORMATION

 

 

Item 6. Exhibits

 

No.

Description

31.1

Certification of principal executive officer and principal financial officer pursuant to Rules 13a-14(a) or 15d- 14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.

 

32.1

Certification of principal executive officer and principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.

 

101.INS

XBRL Instance

 

101.SCH

XBRL Taxonomy Extension Schema

 

101.CAL

XBRL Taxonomy Extension Calculation

 

101.DEF

XBRL Taxonomy Extension Definition

 

101.LAB

XBRL Taxonomy Extension Labels

 

101.PRE

XBRL Taxonomy Extension Presentation

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

MIKROS SYSTEMS CORPORATION

 

 

 

 

 

 

 

 

 

November 13, 2018 

By:

/s/ Thomas J. Meaney

 

 

 

 

 

 

 

 

 

    Thomas J. Meaney  
    Chief Executive Officer and Chief Financial Officer  

 

15

EX-31.1 2 ex_128294.htm EXHIBIT 31.1 ex_128294.htm

Exhibit 31.1

 

CERTIFICATION

 

I, Thomas J. Meaney, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Mikros Systems Corporation;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

As the registrant’s sole certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15(d)-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

As the registrant’s sole certifying officer, I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.

 

November 13, 2018

 

/s/ Thomas J. Meaney

Thomas J. Meaney

Chief Executive Officer and Chief Financial Officer

 

 

EX-32.1 3 ex_128295.htm EXHIBIT 32.1 ex_128295.htm

Exhibit 32.1

 

Certifications Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

(18 U.S.C. Section 1350)

 

In connection with the Quarterly Report (the “report”) of Mikros Systems Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2018, as filed with the Securities and Exchange Commission, I, Thomas J. Meaney, President and Chief Financial Officer of the Company, do hereby certify, pursuant to Section 906 of the Sarbanes- Oxley Act of 2002 (18 U.S.C. § 1350), that to my knowledge:

 

 

(1)

the report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

November 13, 2018 

By:

/s/ Thomas J. Meaney

 

 

 

Thomas J. Meaney 

 

 

 

Chief Executive Officer and Chief Financial Officer 

 

 

 

EX-101.INS 4 mkrs-20180930.xml XBRL INSTANCE DOCUMENT false --12-31 Q3 2018 2018-09-30 10-Q 0000317340 35568775 Yes false Non-accelerated Filer MIKROS SYSTEMS CORP true mkrs 648739 530477 1882829 1587069 37029 29005 274161 195537 238967 75000 0 115000 -238967 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Salaries</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,047</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69,727</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">159,237</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,193</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38,401</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,645</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,047</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,351</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">198,882</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 224 35 360697 482873 1941582 1697997 102342 106570 10101805 10087843 13682 13682 5250 5250 15750 15750 70000 60000 80000 60000 3609141 3159354 3311548 2943716 1173177 858868 1288806 1079789 115629 220921 0.01 0.01 60000000 60000000 35568775 35561775 35568775 35561775 355689 355619 25250 18750 776493 636128 3055932 1909246 -47032 63260 55777 8745 63795 33657 0.01 0.01 0.01 0.01 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note </div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">&#x2013;</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Income</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Per</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Share</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Net income per common share information is as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic earnings per common share:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,029</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,005</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">274,161</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195,537</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average basic shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,568,775</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,555,742</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,308,668</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,246,893</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic income per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dilutive earnings per common share:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income allocable to common shareholders</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,029</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,005</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">274,161</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195,537</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average shares outstanding - basic</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,568,775</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,555,742</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,308,668</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,246,893</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Diluted effect:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Stock options</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,347</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">82,200</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,364</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75,400</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested restricted stock</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">231,418</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">224,263</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">215,773</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202,564</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average dilutive shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,876,540</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,862,205</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,594,805</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,524,857</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dilutive income per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Diluted net income per share for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> reflect the following potential common shares, as the effect would be antidilutive.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested restricted stock</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div></div> 0.32 0.35 0.21 765816 575926 P6Y 69966 54101 139945 137683 69979 83582 42485 37557 413731 379407 1287668 1218694 1117452 915492 3570784 3138210 55304 6309 401525 334601 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div> &#x2013; Income Tax Matters</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>we estimated our annual effective tax rate for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> to be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32%.</div> We recognized a tax expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$18,275</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$127,364</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018. </div>At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>the difference from the statutory federal income tax rate is attributable to state income taxes and certain permanent book-tax differences.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company conducts an on-going analysis to review its net deferred tax asset and the need for a related valuation allowance. As a result of this analysis and the actual results of operations, the Company has (increased) decreased its net deferred tax assets by $(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47,032</div>) and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$63,260</div> during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. The change in deferred tax assets is attributable to the changes in various book/tax differences.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2017, </div>new legislation was signed into law reducing the corporate U.S. tax rate from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35%</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21%</div> for tax years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>fully repealing the corporate alternative minimum tax and making the NOL carryforward period indefinite for NOLs generated after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> In accordance with ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740,</div> deferred tax assets and liabilities are required to be measured at the enacted tax rate expected to apply when temporary differences are to be realized or settled. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company re-measured its deferred tax balances based upon the new <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21%</div> tax rate.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">While the Company has completed its provisional analysis of the income tax effects of the new legislation and recorded a reasonable estimate of such effects, the amounts recorded related to the new legislation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>differ, possibly materially, due to, among other things, further refinement of the Company&#x2019;s calculations, changes in interpretations and assumptions that the Company has made, additional guidance that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be issued by the U.S. Government, and actions and related accounting policy decisions the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>take as a result of this legislation. The Company will complete its analysis over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year measurement period ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> later than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 22, 2018, </div>and any adjustments during this measurement period will be included as an adjustment to income tax expense/benefit in the reporting period when such adjustments are determined.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div></div> 18275 127364 -22696 139064 66500 70150 -122176 -140764 243585 -339333 6500 22500 189890 49286 -2990 -1696 8618 27622 76347 82200 70364 75400 231418 224263 215773 202564 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Intangible Assets</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The majority of the Company&#x2019;s intangible assets is a license acquired during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the Company purchased certain software products, intellectual property and related assets from VSE Corporation. The primary software programs purchased were the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs. The Diagnostic Profiler software is used worldwide by several multinational companies for optimized maintenance of diverse product lines. The Diagnostic Profiler is also used by the US Air Force for depot test programs, and Prognostics Framework is used by the US Army for several missile defense systems.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Licenses are amortized using a straight-line method over their estimated life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> years. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> amortization expense related to the Company&#x2019;s license amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,250</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,250</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,750</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,750,</div> respectively, and are included in general and administrative expenses on the Statements of Income and Comprehensive Income.</div></div></div> 322 701 1238 2154 21306 21306 1301063 1139469 3609141 3159354 1282133 1117549 18930 21920 210388 171018 350 12350 -98718 -93722 213997 302293 274161 195537 274161 37029 29005 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div></div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">&#x2013;</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Recent</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Accounting</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Pronouncements</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Revenue from Contracts with Customers, as amended (commonly referred to as ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>), which replaces numerous requirements in U.S. GAAP, including industry-specific requirements, and provides companies with a single revenue recognition model for recognizing revenue from contracts with customers and significantly expanded the disclosure requirements for revenue arrangements. The new standard, as amended, was effective for the Company for interim and annual reporting periods beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:16pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:0.15pt;">As discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,</div> the Company adopted ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> using the modified retrospective transition method. Results for reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>are presented under ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> while prior period comparative information has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been restated and continues to be reported in accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605,</div> Revenue Recognition, the accounting standard in effect for periods ended prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018. </div>Based on contracts in process at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company determined that the impact of the adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> is immaterial and that the Company will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recognize any of the accelerated net sales at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>in the Company&#x2019;s statements of operations for any historical or future period.</div></div> 1062470 909884 3170497 2805763 54982 5608 400287 332447 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">&#x2013;</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Basis</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">of</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Presentation</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The financial statements included herein have been prepared by Mikros Systems Corporation (the &#x201c;Company&#x201d;) pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In the opinion of the Company&#x2019;s management, the accompanying unaudited interim condensed financial statements contain all adjustments, consisting solely of those which are of a normal recurring nature, necessary to present fairly its financial position as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>the results of its operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> changes in stockholders&#x2019; equity from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and cash flows for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> 2263 4983 96455 88739 0.01 0.01 5000000 5000000 0 0 0 0 81160 72542 350 12350 40000 240980 130370 24630 2013 -90370 240980 115000 40000 171837 123311 7047 68158 69727 159237 14000 12193 38401 39645 21047 80351 108128 198882 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Research and Development Expense</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Research and Development expenditures for research and development of the Company's products are expensed when incurred and are included in general and administrative expenses. The Company recognized research and development costs as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table style="margin-right: 15%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Salaries</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,047</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69,727</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">159,237</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,193</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38,401</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,645</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,047</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,351</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,128</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">198,882</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div> -8149416 -8423577 1893945 1551620 6626716 5047456 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Revenue</div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;">Recognition</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We provide our products and services under fixed-price and cost-reimbursable contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss. Cost-reimbursable contracts provide for the payment of allowable costs incurred during performance of the contract. We also enter into cost-plus-fixed-fee contracts. The fixed-fee in a cost-plus-fixed-fee contract is negotiated at the inception of the contract and that fixed-fee does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> vary with actual costs. We account for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> or more contracts were negotiated and executed at or near the same time or were negotiated with an overall profit objective. If combined, we treat the combined contracts as a single contract for revenue recognition purposes.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or more performance obligations. The products and services in our contracts are typically <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> distinct from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> another due to their complex relationships and the significant contract management functions required to perform under the contract. Accordingly, our contracts are typically accounted for as <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> performance obligation. Significant judgment is required in determining performance obligations, and these decisions could change the amount of revenue and profit recorded in a given period. We classify net sales as products or services on our consolidated statements of income and comprehensive income based on the predominant attributes of the performance obligations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. Our contracts do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include variable consideration. At the inception of a contract we estimate the transaction price based on our current rights and do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> contemplate future modifications. Contracts are often subsequently modified to include changes in specifications, requirements or price, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>create new or change existing enforceable rights and obligations. Depending on the nature of the modification, we consider whether to account for the modification as an adjustment to the existing contract or as a separate contract. Generally, modifications to our contracts or delivery orders are distinct and will be accounted for as a separate contract.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We recognize revenue as performance obligations are satisfied and the customer obtains control of the products and services. In determining when performance obligations are satisfied, we consider factors such as contract terms, payment terms and whether there is an alternative future use of the product or service. Substantially all of our revenue is recognized over a period of time as we perform under the contract because control of the work in process transfers continuously to the customer. This continuous transfer of control of the work in process to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit, and take control of any work in process.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">For performance obligations to deliver products with continuous transfer of control to the customer, revenue is recognized based on the extent of progress towards completion of the performance obligation, generally using the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer as we incur costs on our contracts. Under the cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation. For performance obligations to provide services to the customer, revenue is recognized over a period of time based on costs incurred as our customer receives and consumes the benefits.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Backlog (i.e., unfulfilled or remaining performance obligations) represents the sales we expect to recognize for our products and services for which control has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet transferred to the customer. The estimated consideration is determined at the outset of the contract and considers the risks related to the technical, schedule and cost impacts to complete the contract. Periodically, we review these risks and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>increase or decrease backlog accordingly. As the risks on such contracts are successfully retired, the estimated consideration from customers <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be reduced, resulting in a reduction of backlog without a corresponding recognition of sales. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>our ending backlog was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.5</div> million. For arrangements with the DoD, we generally do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> begin work on contracts until funding is appropriated by the customer. Billing timetables and payment terms on our contracts vary based on a number of factors, including the contract type.</div></div></div> 6500000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested restricted stock</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic earnings per common share:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,029</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,005</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">274,161</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195,537</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average basic shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,568,775</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,555,742</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,308,668</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,246,893</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic income per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dilutive earnings per common share:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income allocable to common shareholders</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,029</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,005</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">274,161</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195,537</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average shares outstanding - basic</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,568,775</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,555,742</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,308,668</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,246,893</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Diluted effect:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Stock options</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,347</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">82,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,364</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75,400</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested restricted stock</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">231,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">224,263</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">215,773</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202,564</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average dilutive shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,876,540</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,862,205</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,594,805</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,524,857</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dilutive income per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">December 31,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2017</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance, beginning of the period</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240,980</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Provision for product warranty</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Product warranty expirations</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(238,967</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Product warranty costs paid</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24,630</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,013</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance, end of the period</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">130,370</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 13682 9782 35561775 35568775 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">&#x2013;</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Significant</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Accounting</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">Policies</div><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Revenue</div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;">Recognition</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We provide our products and services under fixed-price and cost-reimbursable contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss. Cost-reimbursable contracts provide for the payment of allowable costs incurred during performance of the contract. We also enter into cost-plus-fixed-fee contracts. The fixed-fee in a cost-plus-fixed-fee contract is negotiated at the inception of the contract and that fixed-fee does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> vary with actual costs. We account for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> or more contracts were negotiated and executed at or near the same time or were negotiated with an overall profit objective. If combined, we treat the combined contracts as a single contract for revenue recognition purposes.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or more performance obligations. The products and services in our contracts are typically <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> distinct from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> another due to their complex relationships and the significant contract management functions required to perform under the contract. Accordingly, our contracts are typically accounted for as <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> performance obligation. Significant judgment is required in determining performance obligations, and these decisions could change the amount of revenue and profit recorded in a given period. We classify net sales as products or services on our consolidated statements of income and comprehensive income based on the predominant attributes of the performance obligations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. Our contracts do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include variable consideration. At the inception of a contract we estimate the transaction price based on our current rights and do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> contemplate future modifications. Contracts are often subsequently modified to include changes in specifications, requirements or price, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>create new or change existing enforceable rights and obligations. Depending on the nature of the modification, we consider whether to account for the modification as an adjustment to the existing contract or as a separate contract. Generally, modifications to our contracts or delivery orders are distinct and will be accounted for as a separate contract.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We recognize revenue as performance obligations are satisfied and the customer obtains control of the products and services. In determining when performance obligations are satisfied, we consider factors such as contract terms, payment terms and whether there is an alternative future use of the product or service. Substantially all of our revenue is recognized over a period of time as we perform under the contract because control of the work in process transfers continuously to the customer. This continuous transfer of control of the work in process to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit, and take control of any work in process.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">For performance obligations to deliver products with continuous transfer of control to the customer, revenue is recognized based on the extent of progress towards completion of the performance obligation, generally using the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer as we incur costs on our contracts. Under the cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation. For performance obligations to provide services to the customer, revenue is recognized over a period of time based on costs incurred as our customer receives and consumes the benefits.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Backlog (i.e., unfulfilled or remaining performance obligations) represents the sales we expect to recognize for our products and services for which control has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet transferred to the customer. The estimated consideration is determined at the outset of the contract and considers the risks related to the technical, schedule and cost impacts to complete the contract. Periodically, we review these risks and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>increase or decrease backlog accordingly. As the risks on such contracts are successfully retired, the estimated consideration from customers <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be reduced, resulting in a reduction of backlog without a corresponding recognition of sales. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>our ending backlog was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.5</div> million. For arrangements with the DoD, we generally do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> begin work on contracts until funding is appropriated by the customer. Billing timetables and payment terms on our contracts vary based on a number of factors, including the contract type.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Warranty</div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;">Expense</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company provides a limited warranty, as defined by the related warranty agreements, for its production units. The Company&#x2019;s warranties require the Company to repair or replace defective products during such warranty period. The Company estimates the costs that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be incurred under its warranty and records a liability in the amount of such costs at the time product revenue is recognized. Factors that affect the Company&#x2019;s warranty liability include the number of units sold, expected and anticipated rates of warranty claims, and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amount as necessary. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company recognized a warranty expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$75,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0,</div> respectively, and for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company recognized a warranty expense (benefit) of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$115,000</div> and $(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238,967</div>), respectively. Since the inception of the ADEPT IDIQ contract in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2010, </div>the Company has delivered <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">224</div> ADEPT units. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35</div> ADEPT units that remain under the limited warranty coverage.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The following table reflects the reserve for product warranty activity for:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">December 31,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2017</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance, beginning of the period</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240,980</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Provision for product warranty</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Product warranty expirations</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(238,967</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Product warranty costs paid</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24,630</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,013</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance, end of the period</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">130,370</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:20pt;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Research and Development Expense</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Research and Development expenditures for research and development of the Company's products are expensed when incurred and are included in general and administrative expenses. The Company recognized research and development costs as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table style="margin-right: 15%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Salaries</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,047</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69,727</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">159,237</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,193</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38,401</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,645</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,047</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,351</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,128</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">198,882</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Intangible Assets</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The majority of the Company&#x2019;s intangible assets is a license acquired during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the Company purchased certain software products, intellectual property and related assets from VSE Corporation. The primary software programs purchased were the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs. The Diagnostic Profiler software is used worldwide by several multinational companies for optimized maintenance of diverse product lines. The Diagnostic Profiler is also used by the US Air Force for depot test programs, and Prognostics Framework is used by the US Army for several missile defense systems.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Licenses are amortized using a straight-line method over their estimated life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> years. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> amortization expense related to the Company&#x2019;s license amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,250</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,250</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,750</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,750,</div> respectively, and are included in general and administrative expenses on the Statements of Income and Comprehensive Income.</div></div> 130370 40000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Warranty</div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;">Expense</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company provides a limited warranty, as defined by the related warranty agreements, for its production units. The Company&#x2019;s warranties require the Company to repair or replace defective products during such warranty period. The Company estimates the costs that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be incurred under its warranty and records a liability in the amount of such costs at the time product revenue is recognized. Factors that affect the Company&#x2019;s warranty liability include the number of units sold, expected and anticipated rates of warranty claims, and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amount as necessary. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company recognized a warranty expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$75,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0,</div> respectively, and for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company recognized a warranty expense (benefit) of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$115,000</div> and $(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238,967</div>), respectively. Since the inception of the ADEPT IDIQ contract in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2010, </div>the Company has delivered <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">224</div> ADEPT units. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35</div> ADEPT units that remain under the limited warranty coverage.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The following table reflects the reserve for product warranty activity for:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">September 30,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">December 31,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2017</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance, beginning of the period</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240,980</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Provision for product warranty</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Product warranty expirations</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(238,967</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Product warranty costs paid</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24,630</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,013</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance, end of the period</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">130,370</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div> 7000 70 280 350 355619 10087843 -8423577 2019885 355689 10101805 -8149416 2308078 47032 63260 35876540 35862205 35594805 35524857 35568775 35555742 35308668 35246893 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000317340 mkrs:IDIQAgreementMember mkrs:ADEPTUnitsMember 2010-03-01 2018-09-30 0000317340 2017-01-01 2017-09-30 0000317340 us-gaap:RestrictedStockMember 2017-01-01 2017-09-30 0000317340 us-gaap:RestrictedStockMember 2017-01-01 2017-09-30 0000317340 us-gaap:LicensingAgreementsMember 2017-01-01 2017-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentOtherCostsMember 2017-01-01 2017-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentSalariesMember 2017-01-01 2017-09-30 0000317340 2017-01-01 2017-12-31 0000317340 2017-07-01 2017-09-30 0000317340 us-gaap:RestrictedStockMember 2017-07-01 2017-09-30 0000317340 us-gaap:RestrictedStockMember 2017-07-01 2017-09-30 0000317340 us-gaap:LicensingAgreementsMember 2017-07-01 2017-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember 2017-07-01 2017-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentOtherCostsMember 2017-07-01 2017-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentSalariesMember 2017-07-01 2017-09-30 0000317340 2018-01-01 2018-09-30 0000317340 us-gaap:RestrictedStockMember 2018-01-01 2018-09-30 0000317340 us-gaap:RestrictedStockMember 2018-01-01 2018-09-30 0000317340 us-gaap:LicensingAgreementsMember 2018-01-01 2018-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentOtherCostsMember 2018-01-01 2018-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentSalariesMember 2018-01-01 2018-09-30 0000317340 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0000317340 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0000317340 us-gaap:PreferredStockMember 2018-01-01 2018-09-30 0000317340 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0000317340 us-gaap:ScenarioForecastMember 2018-01-01 2018-12-31 0000317340 2018-07-01 2018-09-30 0000317340 us-gaap:RestrictedStockMember 2018-07-01 2018-09-30 0000317340 us-gaap:RestrictedStockMember 2018-07-01 2018-09-30 0000317340 us-gaap:LicensingAgreementsMember 2018-07-01 2018-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember 2018-07-01 2018-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentOtherCostsMember 2018-07-01 2018-09-30 0000317340 us-gaap:GeneralAndAdministrativeExpenseMember mkrs:ResearchAndDevelopmentSalariesMember 2018-07-01 2018-09-30 0000317340 2016-12-31 0000317340 2017-09-30 0000317340 2017-12-31 0000317340 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000317340 us-gaap:CommonStockMember 2017-12-31 0000317340 us-gaap:PreferredStockMember 2017-12-31 0000317340 us-gaap:RetainedEarningsMember 2017-12-31 0000317340 2018-09-30 0000317340 mkrs:IDIQAgreementMember mkrs:ADEPTUnitsMember 2018-09-30 0000317340 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000317340 us-gaap:CommonStockMember 2018-09-30 0000317340 us-gaap:PreferredStockMember 2018-09-30 0000317340 us-gaap:RetainedEarningsMember 2018-09-30 0000317340 2018-11-08 EX-101.SCH 5 mkrs-20180930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Statements of Income and Comprehensive Income (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Statements of Shareholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Recent Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Income Tax Matters link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Income Per Share link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 3 - Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 5 - Income Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 3 - Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 3 - Significant Accounting Policies - Reserve for Product Warranty Activity (Details) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 3 - Significant Accounting Policies - Research and Development Expense (Details) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 4 - Income Tax Matters (Details Textual) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 5 - Income Per Share - Weighted Average Shares Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 5 - Income Per Share - Diluted Net Earnings (Loss) Per Share (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 6 mkrs-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 mkrs-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 mkrs-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Other income: Note To Financial Statement Details Textual (Decrease) in accounts payable and accrued expenses Significant Accounting Policies Note 3 - Significant Accounting Policies Additional Paid-in Capital [Member] Note 5 - Income Per Share Note 3 - Significant Accounting Policies - Reserve for Product Warranty Activity (Details) Increase in accrued payroll and payroll taxes Common Stock [Member] Note 3 - Significant Accounting Policies - Research and Development Expense (Details) Preferred Stock [Member] us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Net income before income taxes Income tax expense Income Tax Expense (Benefit), Total Note 5 - Income Per Share - Weighted Average Shares Outstanding (Details) Note 5 - Income Per Share - Diluted Net Earnings (Loss) Per Share (Details) Notes To Financial Statements Equity Components [Axis] Notes To Financial Statements [Abstract] Income Tax Disclosure [Text Block] Equity Component [Domain] Share-based compensation expense us-gaap_LiabilitiesCurrent Total current liabilities us-gaap_RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount us-gaap_FiniteLivedIntangibleAssetUsefulLife Finite-Lived Intangible Asset, Useful Life Expenses: Total expenses mkrs_ProductWarrantyRecoveryExpense Product Warranty (Recovery) Expense The expense (recovery) recorded against (towards) earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers. General and administrative Research and Development Expense, Policy [Policy Text Block] Depreciation and amortization Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period us-gaap_AssetsCurrent Total current assets Amendment Flag General and Administrative Expense [Member] Accounting Policies [Abstract] Significant Accounting Policies [Text Block] us-gaap_CommonStockValue Common stock, par value $.01 per share, authorized 60,000,000 shares, issued and outstanding 35,568,775 and 35,561,775 shares, respectively Research and Development Expense [Table Text Block] Tabular disclosure of research and development expenses incurred. Adjustments to reconcile net income to net cash provided by operating activities: Common stock, authorized (in shares) Research and Development, Other Costs [Member] The other costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) Common stock, outstanding (in shares) Accounts payable and accrued expenses Preferred stock, shares outstanding (in shares) Common stock, issued (in shares) Research and Development, Salaries [Member] The salaries costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Deferred revenue Common stock, par value (in dollars per share) us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Current Fiscal Year End Date Standard Product Warranty, Policy [Policy Text Block] Accrued payroll and payroll taxes us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (Increase) in prepaid expenses and other current assets Document Fiscal Period Focus Document Fiscal Year Focus Product and Service [Axis] Net income allocable to common shareholders mkrs_NetIncomeLossPortionAllocableToCommonStockholdersBasic Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period) that are allocable to common stockholders. Deferred tax assets Document Period End Date Product and Service [Domain] Income Statement Location [Axis] Income Statement Location [Domain] Entity Emerging Growth Company Document Type Preferred stock, convertible, par value $.01 per share, authorized 5,000,000 shares, none issued and outstanding Interim Period, Costs Not Allocable [Domain] Entity Small Business Preferred stock, shares issued (in shares) Intangible Assets, Finite-Lived, Policy [Policy Text Block] us-gaap_PolicyTextBlockAbstract Accounting Policies Document Information [Line Items] Document Information [Table] Preferred stock, shares authorized (in shares) Nature of Expense [Axis] Entity Filer Category Entity Current Reporting Status Licensing Agreements [Member] mkrs_ProductWarrantyAccrualExpirations Product warranty expirations Product warranty accrual expirations. Preferred stock, par value (in dollars per share) IDIQ Agreement [Member] us-gaap_PaymentsToAcquireIntangibleAssets Payments related to intangible assets Contract Revenues us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract Diluted effect: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property and equipment Stock options (in shares) Antidilutive shares (in shares) Weighted average dilutive shares outstanding (in shares) Diluted weighted average number of shares outstanding (in shares) mkrs_UnitsDelivered Units Delivered Number of units delivered. ADEPT Units [Member] A registered trademark of the Company. us-gaap_IncreaseDecreaseInAccountsReceivable (Increase) decrease in receivables on government contracts Cash paid during the period for income taxes Stock compensation mkrs_UnitsToBeDelivered Units to be Delivered Number of units to be delivered. Statement of Comprehensive Income [Abstract] Entity Central Index Key us-gaap_ProductWarrantyAccrualPayments Product warranty costs paid Entity Registrant Name Scenario, Forecast [Member] Current liabilities: Entity [Domain] Legal Entity [Axis] Statement [Table] Scenario [Axis] Provision for product warranty Statement of Financial Position [Abstract] Scenario, Unspecified [Domain] us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease Increase (decrease) in accrued warranty expense Supplement cash flow information: Dilutive income per common share (in dollars per share) Income per common share - diluted (in dollars per share) us-gaap_Assets Total assets Weighted average basic shares outstanding (in shares) Basic weighted average number of shares outstanding (in shares) us-gaap_AmortizationOfIntangibleAssets Amortization of Intangible Assets, Total us-gaap_EarningsPerShareDilutedAbstract Dilutive earnings per common share: Increase in deferred revenue Interest us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent, Total Basic income per common share (in dollars per share) Income per common share - basic (in dollars per share) Property and equipment Cash flows from operating activities Statement of Cash Flows [Abstract] Revenue Recognition, Policy [Policy Text Block] Statement [Line Items] Entity Common Stock, Shares Outstanding (in shares) Statement of Stockholders' Equity [Abstract] Accrued warranty expense Capital in excess of par value Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Product Warranty Liability [Table Text Block] Shareholders' equity: Trading Symbol Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Equity Award [Domain] Current assets: Net income Net income Net income available to common shareholders Award Type [Axis] Exercise of non-restricted stock awards (in shares) us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Less: accumulated amortization us-gaap_TableTextBlock Notes Tables us-gaap_FiniteLivedIntangibleAssetsNet Intangible assets, net Exercise of non-restricted stock awards Intangible assets us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities: Restricted Stock [Member] us-gaap_Liabilities Total liabilities New Accounting Pronouncements and Changes in Accounting Principles [Text Block] us-gaap_OperatingIncomeLoss Income from operations us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash provided by operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities: Prepaid expenses and other current assets Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net increase in cash and cash equivalents Long-term liabilities Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] us-gaap_GrossProfit Gross margin Cost of sales Counterparty Name [Axis] Cash flows from financing activities: Counterparty Name [Domain] us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less: accumulated depreciation us-gaap_PropertyPlantAndEquipmentNet Property and equipment, net us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and shareholders' equity Equipment Furniture & fixtures Leasehold improvements Receivables on government contracts Research and development cost Accumulated deficit Engineering The amount of engineering expenses incurred during the period. Changes in assets and liabilities: us-gaap_StockholdersEquity Total shareholders' equity Balance Balance us-gaap_ProductWarrantyAccrual Balance, beginning of the period Balance, end of the period us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Class of Stock [Axis] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cash flows from investing activities: (Decrease) in long-term liabilities Retained Earnings [Member] Earnings Per Share [Text Block] Deferred taxes Exercise of stock options EX-101.PRE 9 mkrs-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 08, 2018
Document Information [Line Items]    
Entity Registrant Name MIKROS SYSTEMS CORP  
Entity Central Index Key 0000317340  
Trading Symbol mkrs  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Common Stock, Shares Outstanding (in shares)   35,568,775
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 1,288,806 $ 1,173,177
Receivables on government contracts 1,941,582 1,697,997
Prepaid expenses and other current assets 81,160 72,542
Total current assets 3,311,548 2,943,716
Property and equipment    
Equipment 210,388 171,018
Leasehold improvements 21,306 21,306
Furniture & fixtures 42,485 37,557
Less: accumulated depreciation (102,342) (106,570)
Property and equipment, net 171,837 123,311
Intangible assets 139,945 137,683
Less: accumulated amortization (69,966) (54,101)
Intangible assets, net 69,979 83,582
Deferred tax assets 55,777 8,745
Total assets 3,609,141 3,159,354
Current liabilities:    
Accrued payroll and payroll taxes 765,816 575,926
Accounts payable and accrued expenses 360,697 482,873
Accrued warranty expense 130,370 40,000
Deferred revenue 25,250 18,750
Total current liabilities 1,282,133 1,117,549
Long-term liabilities 18,930 21,920
Total liabilities 1,301,063 1,139,469
Shareholders' equity:    
Preferred stock, convertible, par value $.01 per share, authorized 5,000,000 shares, none issued and outstanding
Common stock, par value $.01 per share, authorized 60,000,000 shares, issued and outstanding 35,568,775 and 35,561,775 shares, respectively 355,689 355,619
Capital in excess of par value 10,101,805 10,087,843
Accumulated deficit (8,149,416) (8,423,577)
Total shareholders' equity 2,308,078 2,019,885
Total liabilities and shareholders' equity $ 3,609,141 $ 3,159,354
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
Sep. 30, 2018
Dec. 31, 2017
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 60,000,000 60,000,000
Common stock, issued (in shares) 35,568,775 35,561,775
Common stock, outstanding (in shares) 35,568,775 35,561,775
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Income and Comprehensive Income (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Contract Revenues $ 1,893,945 $ 1,551,620 $ 6,626,716 $ 5,047,456
Cost of sales 776,493 636,128 3,055,932 1,909,246
Gross margin 1,117,452 915,492 3,570,784 3,138,210
Expenses:        
Engineering 648,739 530,477 1,882,829 1,587,069
General and administrative 413,731 379,407 1,287,668 1,218,694
Total expenses 1,062,470 909,884 3,170,497 2,805,763
Income from operations 54,982 5,608 400,287 332,447
Other income:        
Interest 322 701 1,238 2,154
Net income before income taxes 55,304 6,309 401,525 334,601
Income tax expense 18,275 (22,696) 127,364 139,064
Net income available to common shareholders $ 37,029 $ 29,005 $ 274,161 $ 195,537
Income per common share - basic (in dollars per share) $ 0.01 $ 0.01
Basic weighted average number of shares outstanding (in shares) 35,568,775 35,555,742 35,308,668 35,246,893
Income per common share - diluted (in dollars per share) $ 0.01 $ 0.01
Diluted weighted average number of shares outstanding (in shares) 35,876,540 35,862,205 35,594,805 35,524,857
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Shareholders' Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2017 35,561,775      
Balance at Dec. 31, 2017 $ 355,619 $ 10,087,843 $ (8,423,577) $ 2,019,885
Stock compensation 13,682 13,682
Exercise of non-restricted stock awards (in shares) 7,000      
Exercise of non-restricted stock awards $ 70 280 350
Net income 274,161 274,161
Balance (in shares) at Sep. 30, 2018 35,568,775      
Balance at Sep. 30, 2018 $ 355,689 $ 10,101,805 $ (8,149,416) $ 2,308,078
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net income $ 274,161 $ 195,537
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 63,795 33,657
Deferred taxes (47,032) 63,260
Share-based compensation expense 13,682 9,782
Changes in assets and liabilities:    
(Increase) decrease in receivables on government contracts (243,585) 339,333
(Increase) in prepaid expenses and other current assets (8,618) (27,622)
Increase in accrued payroll and payroll taxes 189,890 49,286
(Decrease) in accounts payable and accrued expenses (122,176) (140,764)
Increase (decrease) in accrued warranty expense 90,370 (240,980)
Increase in deferred revenue 6,500 22,500
(Decrease) in long-term liabilities (2,990) (1,696)
Net cash provided by operating activities 213,997 302,293
Cash flows from investing activities:    
Payments related to intangible assets (2,263) (4,983)
Purchase of property and equipment (96,455) (88,739)
Net cash used in investing activities: (98,718) (93,722)
Cash flows from financing activities:    
Exercise of stock options 350 12,350
Net cash provided by financing activities: 350 12,350
Net increase in cash and cash equivalents 115,629 220,921
Cash and cash equivalents, beginning of period 1,173,177 858,868
Cash and cash equivalents, end of period 1,288,806 1,079,789
Supplement cash flow information:    
Cash paid during the period for income taxes $ 66,500 $ 70,150
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 1 - Basis of Presentation
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note
1
Basis
of
Presentation
 
The financial statements included herein have been prepared by Mikros Systems Corporation (the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form
10
-K for the year ended
December 31, 2017.
 
In the opinion of the Company’s management, the accompanying unaudited interim condensed financial statements contain all adjustments, consisting solely of those which are of a normal recurring nature, necessary to present fairly its financial position as of
September 30, 2018,
the results of its operations for the
three
and
nine
months ended
September 30, 2018
and
2017,
changes in stockholders’ equity from
January 1, 2018
to
September 30, 2018
and cash flows for the
nine
months ended
September 30, 2018
and
2017.
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Note
2
Recent
Accounting
Pronouncements
 
In
May 2014,
the FASB issued ASU
2014
-
09,
Revenue from Contracts with Customers, as amended (commonly referred to as ASC
606
), which replaces numerous requirements in U.S. GAAP, including industry-specific requirements, and provides companies with a single revenue recognition model for recognizing revenue from contracts with customers and significantly expanded the disclosure requirements for revenue arrangements. The new standard, as amended, was effective for the Company for interim and annual reporting periods beginning on
January 1, 2018.
 
As discussed in Note
3,
the Company adopted ASC
606
using the modified retrospective transition method. Results for reporting periods beginning after
December 31, 2017
are presented under ASC
606,
while prior period comparative information has
not
been restated and continues to be reported in accordance with ASC
605,
Revenue Recognition, the accounting standard in effect for periods ended prior to
January 1, 2018.
Based on contracts in process at
December 31, 2017,
the Company determined that the impact of the adoption of ASC
606
is immaterial and that the Company will
not
recognize any of the accelerated net sales at
January 1, 2018
in the Company’s statements of operations for any historical or future period.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Significant Accounting Policies
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
Note
3
Significant
Accounting
Policies
 
Revenue
Recognition
 
We provide our products and services under fixed-price and cost-reimbursable contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss. Cost-reimbursable contracts provide for the payment of allowable costs incurred during performance of the contract. We also enter into cost-plus-fixed-fee contracts. The fixed-fee in a cost-plus-fixed-fee contract is negotiated at the inception of the contract and that fixed-fee does
not
vary with actual costs. We account for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
 
We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether
two
or more contracts were negotiated and executed at or near the same time or were negotiated with an overall profit objective. If combined, we treat the combined contracts as a single contract for revenue recognition purposes.
 
We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having
one
or more performance obligations. The products and services in our contracts are typically
not
distinct from
one
another due to their complex relationships and the significant contract management functions required to perform under the contract. Accordingly, our contracts are typically accounted for as
one
performance obligation. Significant judgment is required in determining performance obligations, and these decisions could change the amount of revenue and profit recorded in a given period. We classify net sales as products or services on our consolidated statements of income and comprehensive income based on the predominant attributes of the performance obligations.
 
We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. Our contracts do
not
include variable consideration. At the inception of a contract we estimate the transaction price based on our current rights and do
not
contemplate future modifications. Contracts are often subsequently modified to include changes in specifications, requirements or price, which
may
create new or change existing enforceable rights and obligations. Depending on the nature of the modification, we consider whether to account for the modification as an adjustment to the existing contract or as a separate contract. Generally, modifications to our contracts or delivery orders are distinct and will be accounted for as a separate contract.
 
We recognize revenue as performance obligations are satisfied and the customer obtains control of the products and services. In determining when performance obligations are satisfied, we consider factors such as contract terms, payment terms and whether there is an alternative future use of the product or service. Substantially all of our revenue is recognized over a period of time as we perform under the contract because control of the work in process transfers continuously to the customer. This continuous transfer of control of the work in process to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit, and take control of any work in process.
 
For performance obligations to deliver products with continuous transfer of control to the customer, revenue is recognized based on the extent of progress towards completion of the performance obligation, generally using the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer as we incur costs on our contracts. Under the cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation. For performance obligations to provide services to the customer, revenue is recognized over a period of time based on costs incurred as our customer receives and consumes the benefits.
 
Backlog (i.e., unfulfilled or remaining performance obligations) represents the sales we expect to recognize for our products and services for which control has
not
yet transferred to the customer. The estimated consideration is determined at the outset of the contract and considers the risks related to the technical, schedule and cost impacts to complete the contract. Periodically, we review these risks and
may
increase or decrease backlog accordingly. As the risks on such contracts are successfully retired, the estimated consideration from customers
may
be reduced, resulting in a reduction of backlog without a corresponding recognition of sales. As of
September 30, 2018,
our ending backlog was
$6.5
million. For arrangements with the DoD, we generally do
not
begin work on contracts until funding is appropriated by the customer. Billing timetables and payment terms on our contracts vary based on a number of factors, including the contract type.
 
Warranty
Expense
 
The Company provides a limited warranty, as defined by the related warranty agreements, for its production units. The Company’s warranties require the Company to repair or replace defective products during such warranty period. The Company estimates the costs that
may
be incurred under its warranty and records a liability in the amount of such costs at the time product revenue is recognized. Factors that affect the Company’s warranty liability include the number of units sold, expected and anticipated rates of warranty claims, and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amount as necessary. During the
three
months ended
September 30, 2018
and
2017,
the Company recognized a warranty expense of
$75,000
and
$0,
respectively, and for the
nine
months ended
September 30, 2018
and
2017,
the Company recognized a warranty expense (benefit) of
$115,000
and $(
238,967
), respectively. Since the inception of the ADEPT IDIQ contract in
March 2010,
the Company has delivered
224
ADEPT units. As of
September 30, 2018,
there were
35
ADEPT units that remain under the limited warranty coverage.
 
The following table reflects the reserve for product warranty activity for:
 
   
September 30,
   
December 31,
 
   
2018
   
2017
 
Balance, beginning of the period
  $
40,000
    $
240,980
 
Provision for product warranty
   
115,000
     
40,000
 
Product warranty expirations
   
-
     
(238,967
)
Product warranty costs paid
   
(24,630
)    
(2,013
)
Balance, end of the period
  $
130,370
    $
40,000
 
 
Research and Development Expense
 
Research and Development expenditures for research and development of the Company's products are expensed when incurred and are included in general and administrative expenses. The Company recognized research and development costs as follows:
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2018
   
2017
   
2018
   
2017
 
Salaries
  $
7,047
    $
68,158
    $
69,727
    $
159,237
 
Other costs
   
14,000
     
12,193
     
38,401
     
39,645
 
    $
21,047
    $
80,351
    $
108,128
    $
198,882
 
 
Intangible Assets
The majority of the Company’s intangible assets is a license acquired during
2015.
In
July 2015,
the Company purchased certain software products, intellectual property and related assets from VSE Corporation. The primary software programs purchased were the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs. The Diagnostic Profiler software is used worldwide by several multinational companies for optimized maintenance of diverse product lines. The Diagnostic Profiler is also used by the US Air Force for depot test programs, and Prognostics Framework is used by the US Army for several missile defense systems.
 
Licenses are amortized using a straight-line method over their estimated life of
six
years. For the
three
and
nine
months ended
September 30, 2018
and
2017,
amortization expense related to the Company’s license amounted to
$5,250
and
$5,250
and
$15,750
and
$15,750,
respectively, and are included in general and administrative expenses on the Statements of Income and Comprehensive Income.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Income Tax Matters
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
Note
4
– Income Tax Matters
 
At
September 30, 2018,
we estimated our annual effective tax rate for
2018
to be
32%.
We recognized a tax expense of
$18,275
and
$127,364
for the
three
and
nine
months ended
September 30, 2018.
At
September 30, 2018,
the difference from the statutory federal income tax rate is attributable to state income taxes and certain permanent book-tax differences.
 
The Company conducts an on-going analysis to review its net deferred tax asset and the need for a related valuation allowance. As a result of this analysis and the actual results of operations, the Company has (increased) decreased its net deferred tax assets by $(
47,032
) and
$63,260
during the
nine
months ended
September 30, 2018
and
2017,
respectively. The change in deferred tax assets is attributable to the changes in various book/tax differences.
 
In
December 2017,
new legislation was signed into law reducing the corporate U.S. tax rate from
35%
to
21%
for tax years beginning after
December 31, 2017,
fully repealing the corporate alternative minimum tax and making the NOL carryforward period indefinite for NOLs generated after
2017.
In accordance with ASC Topic
740,
deferred tax assets and liabilities are required to be measured at the enacted tax rate expected to apply when temporary differences are to be realized or settled. As of
December 31, 2017,
the Company re-measured its deferred tax balances based upon the new
21%
tax rate.
 
While the Company has completed its provisional analysis of the income tax effects of the new legislation and recorded a reasonable estimate of such effects, the amounts recorded related to the new legislation
may
differ, possibly materially, due to, among other things, further refinement of the Company’s calculations, changes in interpretations and assumptions that the Company has made, additional guidance that
may
be issued by the U.S. Government, and actions and related accounting policy decisions the Company
may
take as a result of this legislation. The Company will complete its analysis over a
one
-year measurement period ending
no
later than
December 22, 2018,
and any adjustments during this measurement period will be included as an adjustment to income tax expense/benefit in the reporting period when such adjustments are determined.
 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Income Per Share
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Earnings Per Share [Text Block]
Note
5
Income
Per
Share
 
Net income per common share information is as follows:
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2018
   
2017
   
2018
   
2017
 
Basic earnings per common share:
                               
Net income
  $
37,029
    $
29,005
    $
274,161
    $
195,537
 
                                 
Weighted average basic shares outstanding
   
35,568,775
     
35,555,742
     
35,308,668
     
35,246,893
 
                                 
Basic income per common share
  $
-
    $
-
    $
0.01
    $
0.01
 
                                 
Dilutive earnings per common share:
                               
Net income allocable to common shareholders
  $
37,029
    $
29,005
    $
274,161
    $
195,537
 
                                 
Weighted average shares outstanding - basic
   
35,568,775
     
35,555,742
     
35,308,668
     
35,246,893
 
Diluted effect:
                               
Stock options
   
76,347
     
82,200
     
70,364
     
75,400
 
Unvested restricted stock
   
231,418
     
224,263
     
215,773
     
202,564
 
Weighted average dilutive shares outstanding
   
35,876,540
     
35,862,205
     
35,594,805
     
35,524,857
 
                                 
Dilutive income per common share
  $
-
    $
-
    $
0.01
    $
0.01
 
 
Diluted net income per share for the
three
and
nine
months ended
September 30, 2018
and
2017
does
not
reflect the following potential common shares, as the effect would be antidilutive.
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2018
   
2017
   
2018
   
2017
 
                                 
Unvested restricted stock
   
70,000
     
60,000
     
80,000
     
60,000
 
 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Revenue Recognition, Policy [Policy Text Block]
Revenue
Recognition
 
We provide our products and services under fixed-price and cost-reimbursable contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss. Cost-reimbursable contracts provide for the payment of allowable costs incurred during performance of the contract. We also enter into cost-plus-fixed-fee contracts. The fixed-fee in a cost-plus-fixed-fee contract is negotiated at the inception of the contract and that fixed-fee does
not
vary with actual costs. We account for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
 
We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether
two
or more contracts were negotiated and executed at or near the same time or were negotiated with an overall profit objective. If combined, we treat the combined contracts as a single contract for revenue recognition purposes.
 
We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having
one
or more performance obligations. The products and services in our contracts are typically
not
distinct from
one
another due to their complex relationships and the significant contract management functions required to perform under the contract. Accordingly, our contracts are typically accounted for as
one
performance obligation. Significant judgment is required in determining performance obligations, and these decisions could change the amount of revenue and profit recorded in a given period. We classify net sales as products or services on our consolidated statements of income and comprehensive income based on the predominant attributes of the performance obligations.
 
We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. Our contracts do
not
include variable consideration. At the inception of a contract we estimate the transaction price based on our current rights and do
not
contemplate future modifications. Contracts are often subsequently modified to include changes in specifications, requirements or price, which
may
create new or change existing enforceable rights and obligations. Depending on the nature of the modification, we consider whether to account for the modification as an adjustment to the existing contract or as a separate contract. Generally, modifications to our contracts or delivery orders are distinct and will be accounted for as a separate contract.
 
We recognize revenue as performance obligations are satisfied and the customer obtains control of the products and services. In determining when performance obligations are satisfied, we consider factors such as contract terms, payment terms and whether there is an alternative future use of the product or service. Substantially all of our revenue is recognized over a period of time as we perform under the contract because control of the work in process transfers continuously to the customer. This continuous transfer of control of the work in process to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit, and take control of any work in process.
 
For performance obligations to deliver products with continuous transfer of control to the customer, revenue is recognized based on the extent of progress towards completion of the performance obligation, generally using the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer as we incur costs on our contracts. Under the cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation. For performance obligations to provide services to the customer, revenue is recognized over a period of time based on costs incurred as our customer receives and consumes the benefits.
 
Backlog (i.e., unfulfilled or remaining performance obligations) represents the sales we expect to recognize for our products and services for which control has
not
yet transferred to the customer. The estimated consideration is determined at the outset of the contract and considers the risks related to the technical, schedule and cost impacts to complete the contract. Periodically, we review these risks and
may
increase or decrease backlog accordingly. As the risks on such contracts are successfully retired, the estimated consideration from customers
may
be reduced, resulting in a reduction of backlog without a corresponding recognition of sales. As of
September 30, 2018,
our ending backlog was
$6.5
million. For arrangements with the DoD, we generally do
not
begin work on contracts until funding is appropriated by the customer. Billing timetables and payment terms on our contracts vary based on a number of factors, including the contract type.
Standard Product Warranty, Policy [Policy Text Block]
Warranty
Expense
 
The Company provides a limited warranty, as defined by the related warranty agreements, for its production units. The Company’s warranties require the Company to repair or replace defective products during such warranty period. The Company estimates the costs that
may
be incurred under its warranty and records a liability in the amount of such costs at the time product revenue is recognized. Factors that affect the Company’s warranty liability include the number of units sold, expected and anticipated rates of warranty claims, and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amount as necessary. During the
three
months ended
September 30, 2018
and
2017,
the Company recognized a warranty expense of
$75,000
and
$0,
respectively, and for the
nine
months ended
September 30, 2018
and
2017,
the Company recognized a warranty expense (benefit) of
$115,000
and $(
238,967
), respectively. Since the inception of the ADEPT IDIQ contract in
March 2010,
the Company has delivered
224
ADEPT units. As of
September 30, 2018,
there were
35
ADEPT units that remain under the limited warranty coverage.
 
The following table reflects the reserve for product warranty activity for:
 
   
September 30,
   
December 31,
 
   
2018
   
2017
 
Balance, beginning of the period
  $
40,000
    $
240,980
 
Provision for product warranty
   
115,000
     
40,000
 
Product warranty expirations
   
-
     
(238,967
)
Product warranty costs paid
   
(24,630
)    
(2,013
)
Balance, end of the period
  $
130,370
    $
40,000
 
Research and Development Expense, Policy [Policy Text Block]
Research and Development Expense
 
Research and Development expenditures for research and development of the Company's products are expensed when incurred and are included in general and administrative expenses. The Company recognized research and development costs as follows:
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2018
   
2017
   
2018
   
2017
 
Salaries
  $
7,047
    $
68,158
    $
69,727
    $
159,237
 
Other costs
   
14,000
     
12,193
     
38,401
     
39,645
 
    $
21,047
    $
80,351
    $
108,128
    $
198,882
 
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Intangible Assets
The majority of the Company’s intangible assets is a license acquired during
2015.
In
July 2015,
the Company purchased certain software products, intellectual property and related assets from VSE Corporation. The primary software programs purchased were the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs. The Diagnostic Profiler software is used worldwide by several multinational companies for optimized maintenance of diverse product lines. The Diagnostic Profiler is also used by the US Air Force for depot test programs, and Prognostics Framework is used by the US Army for several missile defense systems.
 
Licenses are amortized using a straight-line method over their estimated life of
six
years. For the
three
and
nine
months ended
September 30, 2018
and
2017,
amortization expense related to the Company’s license amounted to
$5,250
and
$5,250
and
$15,750
and
$15,750,
respectively, and are included in general and administrative expenses on the Statements of Income and Comprehensive Income.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2018
Notes Tables  
Schedule of Product Warranty Liability [Table Text Block]
   
September 30,
   
December 31,
 
   
2018
   
2017
 
Balance, beginning of the period
  $
40,000
    $
240,980
 
Provision for product warranty
   
115,000
     
40,000
 
Product warranty expirations
   
-
     
(238,967
)
Product warranty costs paid
   
(24,630
)    
(2,013
)
Balance, end of the period
  $
130,370
    $
40,000
 
Research and Development Expense [Table Text Block]
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2018
   
2017
   
2018
   
2017
 
Salaries
  $
7,047
    $
68,158
    $
69,727
    $
159,237
 
Other costs
   
14,000
     
12,193
     
38,401
     
39,645
 
    $
21,047
    $
80,351
    $
108,128
    $
198,882
 
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Income Per Share (Tables)
9 Months Ended
Sep. 30, 2018
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2018
   
2017
   
2018
   
2017
 
Basic earnings per common share:
                               
Net income
  $
37,029
    $
29,005
    $
274,161
    $
195,537
 
                                 
Weighted average basic shares outstanding
   
35,568,775
     
35,555,742
     
35,308,668
     
35,246,893
 
                                 
Basic income per common share
  $
-
    $
-
    $
0.01
    $
0.01
 
                                 
Dilutive earnings per common share:
                               
Net income allocable to common shareholders
  $
37,029
    $
29,005
    $
274,161
    $
195,537
 
                                 
Weighted average shares outstanding - basic
   
35,568,775
     
35,555,742
     
35,308,668
     
35,246,893
 
Diluted effect:
                               
Stock options
   
76,347
     
82,200
     
70,364
     
75,400
 
Unvested restricted stock
   
231,418
     
224,263
     
215,773
     
202,564
 
Weighted average dilutive shares outstanding
   
35,876,540
     
35,862,205
     
35,594,805
     
35,524,857
 
                                 
Dilutive income per common share
  $
-
    $
-
    $
0.01
    $
0.01
 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2018
   
2017
   
2018
   
2017
 
                                 
Unvested restricted stock
   
70,000
     
60,000
     
80,000
     
60,000
 
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Significant Accounting Policies (Details Textual)
3 Months Ended 9 Months Ended 103 Months Ended
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Sep. 30, 2018
USD ($)
Revenue, Remaining Performance Obligation, Amount $ 6,500,000   $ 6,500,000   $ 6,500,000
Product Warranty (Recovery) Expense 75,000 $ 0 $ 115,000 $ (238,967)  
Licensing Agreements [Member]          
Finite-Lived Intangible Asset, Useful Life     6 years    
Amortization of Intangible Assets, Total $ 5,250 $ 15,750 $ 5,250 $ 15,750  
IDIQ Agreement [Member] | ADEPT Units [Member]          
Units Delivered         224
Units to be Delivered 35   35   35
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Significant Accounting Policies - Reserve for Product Warranty Activity (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Balance, beginning of the period $ 40,000 $ 240,980
Provision for product warranty 115,000 40,000
Product warranty expirations (238,967)
Product warranty costs paid (24,630) (2,013)
Balance, end of the period $ 130,370 $ 40,000
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Significant Accounting Policies - Research and Development Expense (Details) - General and Administrative Expense [Member] - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Research and development cost $ 21,047 $ 80,351 $ 108,128 $ 198,882
Research and Development, Salaries [Member]        
Research and development cost 7,047 68,158 69,727 159,237
Research and Development, Other Costs [Member]        
Research and development cost $ 14,000 $ 12,193 $ 38,401 $ 39,645
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Income Tax Matters (Details Textual) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2018
Dec. 31, 2017
Income Tax Expense (Benefit), Total $ 18,275 $ (22,696) $ 127,364 $ 139,064    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount     $ 47,032 $ 63,260    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent           35.00%
Scenario, Forecast [Member]            
Effective Income Tax Rate Reconciliation, Percent, Total         32.00%  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent         21.00%  
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Income Per Share - Weighted Average Shares Outstanding (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Net income $ 37,029 $ 29,005 $ 274,161 $ 195,537
Weighted average basic shares outstanding (in shares) 35,568,775 35,555,742 35,308,668 35,246,893
Basic income per common share (in dollars per share) $ 0.01 $ 0.01
us-gaap_EarningsPerShareDilutedAbstract        
Net income allocable to common shareholders $ 37,029 $ 29,005 $ 274,161 $ 195,537
Weighted average basic shares outstanding (in shares) 35,568,775 35,555,742 35,308,668 35,246,893
us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract        
Stock options (in shares) 76,347 82,200 70,364 75,400
Weighted average dilutive shares outstanding (in shares) 35,876,540 35,862,205 35,594,805 35,524,857
Dilutive income per common share (in dollars per share) $ 0.01 $ 0.01
Restricted Stock [Member]        
us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract        
Stock options (in shares) 231,418 224,263 215,773 202,564
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Income Per Share - Diluted Net Earnings (Loss) Per Share (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Restricted Stock [Member]        
Antidilutive shares (in shares) 70,000 60,000 80,000 60,000
EXCEL 30 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end
XML 31 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 32 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 34 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 49 116 1 false 13 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.mikrossystems.com/20180930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Balance Sheets (Current Period Unaudited) Sheet http://www.mikrossystems.com/20180930/role/statement-condensed-balance-sheets-current-period-unaudited Condensed Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.mikrossystems.com/20180930/role/statement-condensed-balance-sheets-current-period-unaudited-parentheticals Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Statements of Income and Comprehensive Income (Unaudited) Sheet http://www.mikrossystems.com/20180930/role/statement-condensed-statements-of-income-and-comprehensive-income-unaudited Condensed Statements of Income and Comprehensive Income (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Statements of Shareholders' Equity (Unaudited) Sheet http://www.mikrossystems.com/20180930/role/statement-condensed-statements-of-shareholders-equity-unaudited Condensed Statements of Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://www.mikrossystems.com/20180930/role/statement-condensed-statements-of-cash-flows-unaudited Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Basis of Presentation Sheet http://www.mikrossystems.com/20180930/role/statement-note-1-basis-of-presentation Note 1 - Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Recent Accounting Pronouncements Sheet http://www.mikrossystems.com/20180930/role/statement-note-2-recent-accounting-pronouncements Note 2 - Recent Accounting Pronouncements Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Significant Accounting Policies Sheet http://www.mikrossystems.com/20180930/role/statement-note-3-significant-accounting-policies Note 3 - Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Income Tax Matters Sheet http://www.mikrossystems.com/20180930/role/statement-note-4-income-tax-matters Note 4 - Income Tax Matters Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Income Per Share Sheet http://www.mikrossystems.com/20180930/role/statement-note-5-income-per-share Note 5 - Income Per Share Notes 11 false false R12.htm 011 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.mikrossystems.com/20180930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.mikrossystems.com/20180930/role/statement-note-2-recent-accounting-pronouncements 12 false false R13.htm 012 - Disclosure - Note 3 - Significant Accounting Policies (Tables) Sheet http://www.mikrossystems.com/20180930/role/statement-note-3-significant-accounting-policies-tables Note 3 - Significant Accounting Policies (Tables) Tables http://www.mikrossystems.com/20180930/role/statement-note-3-significant-accounting-policies 13 false false R14.htm 013 - Disclosure - Note 5 - Income Per Share (Tables) Sheet http://www.mikrossystems.com/20180930/role/statement-note-5-income-per-share-tables Note 5 - Income Per Share (Tables) Tables http://www.mikrossystems.com/20180930/role/statement-note-5-income-per-share 14 false false R15.htm 014 - Disclosure - Note 3 - Significant Accounting Policies (Details Textual) Sheet http://www.mikrossystems.com/20180930/role/statement-note-3-significant-accounting-policies-details-textual Note 3 - Significant Accounting Policies (Details Textual) Details http://www.mikrossystems.com/20180930/role/statement-note-3-significant-accounting-policies-tables 15 false false R16.htm 015 - Disclosure - Note 3 - Significant Accounting Policies - Reserve for Product Warranty Activity (Details) Sheet http://www.mikrossystems.com/20180930/role/statement-note-3-significant-accounting-policies-reserve-for-product-warranty-activity-details Note 3 - Significant Accounting Policies - Reserve for Product Warranty Activity (Details) Details 16 false false R17.htm 016 - Disclosure - Note 3 - Significant Accounting Policies - Research and Development Expense (Details) Sheet http://www.mikrossystems.com/20180930/role/statement-note-3-significant-accounting-policies-research-and-development-expense-details Note 3 - Significant Accounting Policies - Research and Development Expense (Details) Details 17 false false R18.htm 017 - Disclosure - Note 4 - Income Tax Matters (Details Textual) Sheet http://www.mikrossystems.com/20180930/role/statement-note-4-income-tax-matters-details-textual Note 4 - Income Tax Matters (Details Textual) Details http://www.mikrossystems.com/20180930/role/statement-note-4-income-tax-matters 18 false false R19.htm 018 - Disclosure - Note 5 - Income Per Share - Weighted Average Shares Outstanding (Details) Sheet http://www.mikrossystems.com/20180930/role/statement-note-5-income-per-share-weighted-average-shares-outstanding-details Note 5 - Income Per Share - Weighted Average Shares Outstanding (Details) Details 19 false false R20.htm 019 - Disclosure - Note 5 - Income Per Share - Diluted Net Earnings (Loss) Per Share (Details) Sheet http://www.mikrossystems.com/20180930/role/statement-note-5-income-per-share-diluted-net-earnings-loss-per-share-details Note 5 - Income Per Share - Diluted Net Earnings (Loss) Per Share (Details) Details 20 false false All Reports Book All Reports mkrs-20180930.xml mkrs-20180930.xsd mkrs-20180930_cal.xml mkrs-20180930_def.xml mkrs-20180930_lab.xml mkrs-20180930_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 36 0001437749-18-020549-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-18-020549-xbrl.zip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